Published Studies Related to Capital and Codeine (Acetaminophen / Codeine)
Well-designed clinical trials related to Capital and Codeine (Acetaminophen / Codeine)
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee. [2006.04]
Analgesic efficacy of rofecoxib compared with codeine/acetaminophen using a model of acute dental pain. [2005.10]
Well-designed clinical trials possibly related to Capital and Codeine (Acetaminophen / Codeine)
Liver cancer: effects, safety, and cost-effectiveness of controlled-release
oxycodone for pain control after TACE. [2012]
Hospitalization costs of total knee arthroplasty with a continuous femoral nerve block provided only in the hospital versus on an ambulatory basis: a retrospective, case-control, cost-minimization analysis. [2007.01]
Postoperative pain management after craniotomy: evaluation and cost analysis. [2006.10]
Other research related to Capital and Codeine (Acetaminophen / Codeine)
Comparison of ibuprofen and acetaminophen with codeine following cosmetic facial surgery. [2009.10]
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. [2009.08]
Other possibly related research studies
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. [2006.11]
Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. [2006.06]
[Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable] [2006.03]
Prescribing Schedule 8 drugs. [2006.01]
Treatment of pain in juvenile idiopathic arthritis: a survey of pediatric rheumatologists. [2006.02.15]
Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. [2005.10]
Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. [2005.04]
[Increasing importance of opioids in geriatrics] [2005.08]
Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. [2006.12]
Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. [2007]
Prescribing patterns and purchasing costs of long-acting opioids over nine years at an academic oncology hospital. [2007.08.01]
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone. [2007.10]
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. [2007.08]
Short stay pyeloplasty: variables affecting pain and length of stay. [2008.04]
[Variable prescription of opioids to cancer patients in Norway] [2008.05.29]
Cost-effectiveness analysis of the analgesic therapy of postoperative pain. [2008.01]
Medicaid Prior Authorization and Controlled-Release Oxycodone. [2008.06]
Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. [2008.09]
Epidemiology of opioid pharmacy claims in the United States. [2008.05]
Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective. [2008.10]
Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. [2009.07]
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. [2009.07]
Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. [2008.09]
[Morphine or oxycodone tablets for pain?] [2010.08.12]
Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. [2010.04]
[Cost-effective analysis of rotation from sustained-release morphine tablet to transdermal fentanyl of matrix type or sustained-release oxycodone tablet] [2009.12]
Trends in opioid consumption in the Nordic countries 2002-2006. [2009.10]
Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective. [2011.07]
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets. [2011.06]
Patterns of postoperative pain medication prescribing after invasive dental procedures. [2011.03]
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain. [2010.09]
The comparative safety of opioids for nonmalignant pain in older adults. [2010.12.13]
[The licit opioid consumption in Denmark]. [2010.11.15]
Hydrocodone: does it have a role in palliative care? [2010.07]
Clonidine as an adjunct to intravenous regional anesthesia: A randomized, double-blind, placebo-controlled dose ranging study. [2011.07]
Imputing at-work productivity loss using results of a randomized controlled trial
comparing tapentadol extended release and oxycodone controlled release for
osteoarthritis pain. [2012]
|
